Ordinary Shares (No Par Value) MAPI - PHARMA LTD. UNDERWRITING AGREEMENTUnderwriting Agreement • February 1st, 2016 • Mapi - Pharma LTD • Pharmaceutical preparations • New York
Mapi - Pharma Ltd., a corporation incorporated under the laws of the state of Israel (the “Company”), proposes to issue and sell to the several Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of [____] authorized but unissued Ordinary Shares, no par value, of the Company (the “Firm Shares”).
SUBSCRIPTION AGREEMENTSubscription Agreement • February 1st, 2016 • Mapi - Pharma LTD • Pharmaceutical preparations
This Subscription Agreement (this “Agreement”) is entered into as of January 31, 2016 (the “Effective Date”), by and between Mapi Pharma Ltd., a company incorporated under the laws of the State of Israel, having a place of business at 16 Einstein St., Ness Ziona 74140, Israel (“Mapi”), and Zhejiang Jingxin Pharmaceutical Co., Ltd., a company incorporated under the laws of the People's Republic of China, having a place of business at NO.800,Xinchang Dadao East Road, Chengguan Town, Xinchang County, Zhejiang Province, China (“Jingxin”). Mapi and Jingxin are sometimes referred to individually as a “Party” and collectively as the “Parties”.
ESCROW AGREEMENTEscrow Agreement • February 1st, 2016 • Mapi - Pharma LTD • Pharmaceutical preparations
This Escrow Agreement (this “Agreement”) is made as of January 31, 2016, by and among Mapi-Pharma Ltd., an Israeli company with offices at 16 Einstein St., Ness Ziona 74140, Israel (the “Company”), Zhejiang Jingxin Pharmaceutical Co., Ltd., a Chinese company with offices at NO.800,Xinchang Dadao East Road, Chengguan Town, Xinchang County, Zhejiang Province, China (the “Investor”), and Meitav Dash Trusts Ltd., as escrow agent (the “Escrow Agent”) (the Company and the Investor are each individually referred to as a “Party” and collectively as the “Parties”).
